-The Hindu New York: Dayamani Barla was presented with the first ever Ellen L. Lutz Indigenous Rights Award by Cultural Survival, an indigenous peoples' rights organisation The Big Apple is renowned as the home of investment banks, glitzy fashion shows and other 21st-century tributes to prodigious wealth accumulation. But on Thursday it played host to a powerful symbol of Indian adivasis' struggle against oppression, Jharkhand activist and journalist Dayamani Barla. On a rainy...
More »SEARCH RESULT
Total Matching Records found : 4031
Depositors from outside add to complaint pile
-The Indian Express Kolkata: AMONG the 6.25 lakh complaints received by Justice Sen Commission, which has been set up by the West Bengal government to inquire into the Saradha Group and other chit fund scams and also to look into ways to return money to investors, many have been submitted by people from other states where the firms were operating. "Since the West Bengal government is the only state government that has...
More »From Bofors to 2G, the same fate-Arun Kumar
-The Hindu The parliamentary committees on the howitzer scam and the stock market scandal protected the powerful and failed to fix accountability. The same is true in the spectrum case The current political situation brings back memories of 1989. The Prime Minister then was under a cloud in the Bofors scam. Many of his close associates like Lalit Suri and Ajitabh Bachchan were accused of wrong-doing. Today, Prime Minister Manmohan Singh and...
More »Ranbaxy's dark chapter-Bhupesh Bhandari
-The Business Standard Why have Indian authorities woken up to the Ranbaxy case only now? The matter had been simmering for several years The Ranbaxy affair is one of the darkest chapters of India's business history. The company has admitted it fudged data so that it could launch its products in the United States. It has now paid $500 million as a penalty to settle the case. It is worse than Ramalinga...
More »New bulk drug export norms to comply with EU standards
-The Hindu The Commerce and Industry Ministry, on Thursday, issued new guidelines for pharmaceutical makers to comply with the European Union (EU) Good Manufacturing Practice (GMP) standards. In a statement issued here, the Ministry says such a move will give a boost to pharma exports from India. "India has demonstrated its keenness to meet international requirements for exports of pharmaceutical products yet again by taking timely action for complying with the new...
More »
